Physician profile
Marc E Wright
NPI 1760788566
$398.52
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $29.34 · 2022: $19.65 · 2023: $21.20 · 2024: $98.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $94.47 | 2019-2024 | Jardiance, Zepbound, Mounjaro |
| Novartis Pharmaceuticals Corporation | $64.83 | 2019 | |
| Amgen INC. | $29.34 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $25.93 | 2024 | |
| Gilead Sciences, INC. | $25.49 | 2019 | |
| Allergan, INC. | $22.72 | 2019 | |
| Eisai INC. | $22.61 | 2024 | |
| Merck Sharp & Dohme LLC | $21.73 | 2024 | M-M-R II, Vaxelis, Gardasil 9 |
| Teva Pharmaceuticals USA, INC. | $21.59 | 2019 | |
| Glaxosmithkline, LLC. | $20.78 | 2019 | |
| Cranial Technologies, INC | $19.65 | 2022 | |
| Therapeuticsmd, INC. | $16.34 | 2019 | |
| Genentech USA, INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.